chr9-96818702-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001001662.3(ZNF782):āc.1321C>Gā(p.Gln441Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000266 in 1,614,034 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001001662.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF782 | ENST00000481138.6 | c.1321C>G | p.Gln441Glu | missense_variant | 6/6 | 1 | NM_001001662.3 | ENSP00000419397.1 | ||
ZNF782 | ENST00000535338.5 | c.1321C>G | p.Gln441Glu | missense_variant | 5/5 | 3 | ENSP00000440624.2 | |||
ZNF782 | ENST00000289032.12 | n.1286C>G | non_coding_transcript_exon_variant | 3/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152150Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000151 AC: 38AN: 251436Hom.: 0 AF XY: 0.000110 AC XY: 15AN XY: 135882
GnomAD4 exome AF: 0.0000287 AC: 42AN: 1461884Hom.: 0 Cov.: 33 AF XY: 0.0000234 AC XY: 17AN XY: 727240
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152150Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74318
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 25, 2022 | The c.1321C>G (p.Q441E) alteration is located in exon 6 (coding exon 4) of the ZNF782 gene. This alteration results from a C to G substitution at nucleotide position 1321, causing the glutamine (Q) at amino acid position 441 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at